Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
BRIEF-Galectin Therapeutics Reports June 30, 2026 Financial Results Aug 14 (Reuters) - Galectin Therapeutics Inc GALT.O:
GALECTIN THERAPEUTICS REPORTS JUNE 30, 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Source text: ID:nGNX6L8ptY
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study